CORRECTION article

Front. Neurol., 18 April 2017

Sec. Neuromuscular Disorders and Peripheral Neuropathies

Volume 8 - 2017 | https://doi.org/10.3389/fneur.2017.00145

Corrigendum: Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan

  • 1. Dagestan State Medical Academy, Makhachkala, Russian Federation

  • 2. S.M. Kirov Military Medical Academy, Saint Petersburg, Russian Federation

  • 3. Kazan Federal University, Kazan, Russian Federation

  • 4. Human Stem Cells Institute, Moscow, Russian Federation

  • 5. Voronezh Regional Clinical Hospital No.1, Voronezh, Russian Federation

  • 6. Ryazan State Medical University, Ryazan, Russian Federation

The “Funding” section should be:

This work was funded by Human Stem Cells Institute PJSC and Roman V. Deev. Theoretical part of this work was supported by Russian Scientific Foundation grant (14-15-00916). Ivan A. Yakovlev and Mikhail O. Mavlikeev were supported by the Russian Government Program of Competitive Growth of Kazan Federal University.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Summary

Keywords

dysferlinopathy, LGMD2B, Miyoshi myopathy, dysferlin, muscular dystrophy

Citation

Umakhanova ZR, Bardakov SN, Mavlikeev MO, Chernova ON, Magomedova RM, Akhmedova PG, Yakovlev IA, Dalgatov GD, Fedotov VP, Isaev AA and Deev RV (2017) Corrigendum: Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan. Front. Neurol. 8:145. doi: 10.3389/fneur.2017.00145

Received

21 March 2017

Accepted

31 March 2017

Published

18 April 2017

Volume

8 - 2017

Edited and reviewed by

Ghazala Hayat, Saint Louis University, USA

Updates

Copyright

*Correspondence: Ivan A. Yakovlev,

Specialty section: This article was submitted to Neuromuscular Diseases, a section of the journal Frontiers in Neurology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics